Market Summary | Market Indexes | Market Movers | Market Sectors | Foreign Markets
A-Z Stock Listings | ETF Screener | Mutual Funds | CEO Wealthmeter | Metals | Oil & Energy
Currencies | Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
Ceragenix Pharmaceuticals, Inc. (OTCBB: CGXP)Add to My Watchlist
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Company Quote
Last Price 0.59 (11.23.09 5:20 PM EST)
Change (%)     - (-)
Volume 100
Open 0.59
Previous Close 0.59
Day High 0.59
Day Low 0.59
Bid 0.47 x 5000
Ask 0.59 x 2500
   
Chart
Intraday | 3 Month | 6 Month | 1 Year
Stock Data
Average Volume 6,778
Shares Outstanding 18.18M
Market Cap 10.7M
Year High 0.90
Year Low 0.16
Earnings Per Share -0.47
P/E Ratio -1.3
Dividend N/A
Yield N/A
   
Related Companies
Symbol Last Change (%)
BMOD 0.15 -0.00 (-2.56%)
GTCB 1.02 -0.08 (-7.27%)
NUXP 0.40 +0.00 (+0.00)
ESMC 1.51 +0.00 (+0.00)
AOLS 0.30 +0.00 (+0.00)
NANM 0.24 -0.02 (-7.69%)
TEAR 1.15 +0.02 (+2.23%)
SNSS 0.31 -0.01 (-3.13%)
News: CGXP
Fri, Aug 28, 2009
EBITDA for Ceragenix Pharmaceuticals Improves 20% - StockTrendNews.com e...
Thu, Aug 27, 2009
Ceragenix Pharmaceuticals' Revenue Up 3944.44% over latest 12 months according to T12-NEWS - StockTrendNews.com s...
Wed, Aug 26, 2009
Four Year High in Free Cash Flow for Ceragenix Pharmaceuticals - StockTrendNews.com f...
OPS Ranking of "7" for Ceragenix Pharmaceuticals Reiterated by StockDiagnostics.com - StockTrendNews.com o...
Ceragenix Pharmaceuticals' Cash Flow from Operations Hits Four Year High - StockTrendNews.com c...
More News
Press Releases: CGXP
Mon, Oct 26, 2009
Second Partner Exercises Option for Exclusive Period to Negotiate Licensing Terms for CeraShield™ Antimicrobial Coating Application - Business Wire
Wed, Sep 09, 2009
NIH Issues $2.87 Million Grant for Development of Ceragenin™ Based Drug to Treat Clostridium difficile and Shigella Gastrointestinal Infections - Business Wire
Tue, Sep 01, 2009
Partner Exercises Option for Exclusive Period to Negotiate Licensing Terms for CeraShield™ Antimicrobial Coating Application - Business Wire
Thu, Aug 13, 2009
Ceragenix Completes Long-Term Antimicrobial Efficacy Test on Treated Silicone Medical Device - Business Wire
Mon, Jul 27, 2009
Ceragenix and MEGAPHARM Enter Into Distribution and Supply Agreement for EpiCeram® - Business Wire
More Press Releases
Blogs: CGXP
Wed, Nov 22, 2006
Spreading the Gospel: Vaccines Prevent Disease - Life Science
Spreading the Gospel: Vaccines Prevent Disease - Life Science
Tue, Nov 21, 2006
Spreading the Gospel: Vaccines Prevent Disease - Life Science
More Blogs
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Stock Updates provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs
Go
track your portfolio
CLOSE WINDOW  
close window
E-mail Article to a Friend